4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
Holding FDMT?
Track your performance easily

4D Molecular Therapeutics (FDMT) Income Statement

282 Followers

4D Molecular Therapeutics Income Statement

Last quarter (Q2 2024), 4D Molecular Therapeutics's total revenue was $5.00K, a decrease of -97.91% from the same quarter last year. In Q2, 4D Molecular Therapeutics's net income was $-34.95M. See 4D Molecular Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 20.22M$ 20.72M$ 3.13M$ 18.04M$ 13.61M$ 6.99M
Cost of Revenue
------
Gross Profit
$ 20.22M$ 20.72M$ 3.13M$ 18.04M$ 13.61M-
Operating Expense
$ 151.44M$ 133.59M$ 113.16M$ 89.37M$ 70.28M$ 52.61M
Operating Income
$ -131.22M$ -112.87M$ -110.03M$ -71.33M$ -56.66M$ -45.63M
Net Non Operating Interest Income Expense
$ 21.55M$ 12.21M$ 2.57M$ 137.00K$ 152.00K$ 1.50M
Other Income Expense
$ -137.00K$ -181.00K$ -35.00K$ 121.00K$ 181.00K$ -5.18M
Pretax Income
$ -109.89M$ -100.84M$ -107.49M$ -71.32M$ -56.69M$ -49.31M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -109.89M$ -100.84M$ -107.49M$ -71.32M$ -56.69M$ -49.31M
Basic EPS
$ -2.22$ -2.58$ -3.32$ -2.57$ -8.82$ -3.94
Diluted EPS
$ -2.22$ -2.58$ -3.32$ -2.57$ -8.82$ -3.94
Basic Average Shares
$ 190.02M$ 39.13M$ 32.35M$ 27.73M$ 6.43M$ 12.52M
Diluted Average Shares
$ 190.02M$ 39.13M$ 32.35M-$ 6.43M$ 12.52M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 151.44M$ 133.59M$ 113.16M$ 89.37M$ 70.28M$ 52.61M
Net Income From Continuing And Discontinued Operation
$ -109.89M$ -100.84M$ -107.49M$ -71.32M$ -56.69M$ -49.31M
Normalized Income
$ -92.18M$ -79.66M---$ -44.17M
Interest Expense
------
EBIT
$ -117.98M$ -112.87M$ -110.03M$ -71.33M$ -56.66M$ -45.63M
EBITDA
$ -111.85M$ -107.12M$ -106.15M$ -68.31M$ -55.22M$ -44.62M
Currency in USD

4D Molecular Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis